That means citation density above industry norm, source-checked claims, methodology disclosure on every guide, and a willingness to argue against our own commercial interest when the evidence calls for it
Moore PW, Malone K, VanValkenburg D, Rando LL, Williams BC, Matejowsky HG, et al
No significant effect on progression of late-onset, high-burden atherosclerotic disease was observed, and there was no significant endothelial cell dysfunction in this animal model
Rasch, B., Bchel, C., Gais, S
Though these drugs have been used to treat type 2 diabetes for nearly two decades, it wasnt until 2021 that the FDA approved one of them Novo Nordisks Wegovy (semaglutide) as a treatment for obesity
It can be acute or chronic